Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.61 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.56 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.56 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.56 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.55 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 3/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5495401 | 0.98 | GSR (0.59) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL19088201 | 0.90 | GSR (0.55) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL17982113 | 0.88 | GSR (0.53) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL7294153 | 0.88 | GNAI3 (0.54) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL16430142 | 0.88 | GSR (0.53) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL29989156 | 0.86 | GSR (0.57) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL5059979 | 0.85 | GSR (0.50) | GSRGNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL18373043 | 0.84 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5667565 | 0.84 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL11771047 | 0.84 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3273793-B1 | AMINO ACID ANIMAL FEED COMPOSITION | BENEMILK OY (FI) | 2020-08-19 | — | — | EP | claimed |
| US-20180070611-A1 | AMINO ACID ANIMAL FEED COMPOSITION | WAN FENG (US) | 2018-03-15 | — | — | US | claimed |
| EP-3273793-A2 | AMINO ACID ANIMAL FEED COMPOSITION | Benemilk Oy (FI) | 2018-01-31 | — | — | EP | claimed |
| WO-2016154583-A2 | AMINO ACID ANIMAL FEED COMPOSITION | BENEMILK OY (FI) | 2016-09-29 | — | — | WO | claimed |
| EP-3233796-B1 | POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS BV (NL) | 2020-08-26 | — | — | EP | disclosed |
| EP-3273793-B1 | AMINO ACID ANIMAL FEED COMPOSITION | BENEMILK OY (FI) | 2020-08-19 | — | — | EP | disclosed |
| EP-3233795-B1 | ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS BV (NL) | 2020-05-13 | — | — | EP | disclosed |
| CN-107108889-B | Alkyd resin composition of multifunctional hydroxyphthalimide monomer compound | 帝斯曼知识产权资产管理有限公司 | 2020-04-21 | — | — | CN | disclosed |
| US-10189783-B2 | Polyfunctional compounds | DSM IP ASSETS B.V. (NL) | 2019-01-29 | — | — | US | disclosed |
| US-10066053-B2 | Alkyd resin compositions | DSM IP ASSETS B.V. (NL) | 2018-09-04 | — | — | US | disclosed |
| US-20180070611-A1 | AMINO ACID ANIMAL FEED COMPOSITION | WAN FENG (US) | 2018-03-15 | — | — | US | disclosed |
| EP-3273793-A2 | AMINO ACID ANIMAL FEED COMPOSITION | Benemilk Oy (FI) | 2018-01-31 | — | — | EP | disclosed |
| WO-2016097404-A1 | ALKYD RESIN COMPOSITIONS OF POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016097403-A1 | POLYFUNCTIONAL HYDROPHTHALIMIDE MONOMER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2016-06-23 | — | — | WO | disclosed |
| CN-102282169-A | Modulation of cellular activity and differentiation of osteoclast-associated receptors | — | 2011-12-14 | — | — | CN | disclosed |
| EP-1100816-B1 | AEROTHRICIN ANALOGS, THEIR PREPARATION AND USE | BASILEA PHARMACEUTICA AG (CH) | 2007-08-08 | — | — | EP | disclosed |
| EP-1251827-B1 | NASALLY ADMINISTRABLE ANTIFUNGAL CYCLIC PEPTIDE COMPOSITIONS | BASILEA PHARMACEUTICA AG (CH) | 2004-05-26 | — | — | EP | disclosed |
| US-6489440-B1 | Cyclic compounds | BASILEA PHARMACEUTICA AG (CH) | 2002-12-03 | — | — | US | disclosed |
| US-20010038824-A1 | Intranasal cyclic peptide formulations | BASILEA PHARMACEUTICA AG (CH) | 2001-11-08 | — | — | US | disclosed |
| CN-1311794-A | Aerothricin analogs, their prepn. and use | HOFFMANN LA ROCHE (CH) | 2001-09-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10189783-B2 | Polyfunctional compounds | H1-3, H1-0, H1-2 | GSR 3450/4885GNAI3 1285/4885GNAO1 2792/4885 |
| US-20010038824-A1 | Intranasal cyclic peptide formulations | VIP, NPPA, SSTR5 | GSR 4171/4885GNAI3 3398/4885GNAO1 3347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.